Study: Salvage targeted therapy can be suitable for elderly patients with NSCLC

Links shared publicly online about this topic.

1,339
total visits

Study: Salvage targeted therapy can be suitable for elderly patients with NSCLC

Research published in the March issue of the Journal of Thoracic Oncology sought to determine whether differences existed in tolerance and efficacy between patients age 70 and over and younger patients with non-small cell lung cancer (NSCLC) receiving salvage targeted therapy with epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) or chemotherapy.

View full resource at news-medical.net

Tags: Cancer, Chemotherapy, Lung Cancer, Non-Small Cell Lung Cancer, Lung, Senior Health, Oncology